share_log

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Heyman Richard A.

SEC ·  Oct 18 05:11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more